Skip to the main content.

Cell and Gene Therapy Series. Part 7 - Manufacturing Paradigms part II

Dr. Dave Seaward : 20 September 2022

Cell and Gene Therapy Series. Part 7 - Manufacturing Paradigms part II

Cell and Gene Blog Series: Part 7 - Future ATMP Manufacturing Paradigms

We wrap up this Cell and Gene series with a final blog - 7. Follow the link to continue learning about the future of ATMPs' manufacturing paradigm.
Mark Wilson - Navigating Innovation in a Slow-Moving Pharma Industry

Mark Wilson - Navigating Innovation in a Slow-Moving Pharma Industry

Georgia Lewis: 11 March 2026

Mark Wilson - Presentation at UK Pharmaceutical & MedTech Innovations event.ISPE UK Affiliate - 12/2/2026 Listening to Mark’s reflections on his 20...

Read More
Optimising Cryovial Filling and Cryopreservation for Reliable Cell Functionality

Optimising Cryovial Filling and Cryopreservation for Reliable Cell Functionality

3P innovation: 10 March 2026

An Integrated Equipment Workflow for Consistent Post-Thaw Viability and Function Recovery

Read More
The challenges of developing combination products: Regulatory complexity and the case for a holistic development strategy

The challenges of developing combination products: Regulatory complexity and the case for a holistic development strategy

Dr. Dave Seaward: 15 February 2026

Drug–device combination products are becoming a defining feature of modern pharmaceutical portfolios, shaping how therapies differentiate, extend...

Read More